IN CASE YOU MISSED IT: Recently, Dr. Juan Pablo Frias presented “The Central Role of Weight Management in the Care of People with Type 2 Diabetes,” where he discussed how weight management is becoming a core pillar of diabetes care and how new therapies are reshaping outcomes across multiple organ systems.
Key highlights:
- Obesity is a major upstream driver of type 2 diabetes and its complications
- Weight management should be a primary goal alongside glycemic control
- GLP-1-based and multi-agonist therapies show benefits for glucose, weight, cardiovascular, renal, and liver outcomes
- Metabolic liver disease (MASLD/MASH) is highly prevalent yet underrecognized in type 2 diabetes
- Simple screening tools like the FIB-4 score can help identify patients at risk for advanced fibrosis
- Early, proactive treatment can change the trajectory of cardiometabolic disease Watch the full recording here: lnkd.in/e2pAedNm Emory Global Diabetes Research Center Emory University Emory University School of Medicine Morehouse School of Medicine Georgia Institute of Technology Rollins School of Public Health at Emory University
